BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:The Michael J. Fox Foundation - Therapeutics Pipeline Program | Re
 search Funding
DTSTART;VALUE=DATE:20230727
DTSTAMP:20260610T042631Z
UID:d87af35499612355cf9b2602b4ff63db33199fd7161f2baad83ce540
CATEGORIES:Call for proposal
DESCRIPTION:Aim:  The Michael J. Fox Foundation (MJFF) funds research to 
 better define\, measure\, and treat Parkinson’s disease as well as criti
 cal tools and other resources to advance that research. The Pre-clinical T
 herapeutics Pipeline Program seeks to accelerate the path of the therapeut
 ic pipeline towards the clinic through the support of ambitious and scient
 ifically robust pre-clinical studies aiming at developing and/or testing t
 reatments and/or interventions that can address the unmet needs of people 
 with PD. To meet this goal\, we are currently only accepting applications 
 from industry groups and academia-industry partnerships.\n\nWhen consideri
 ng applications submitted to this program\, MJFF is interested in programs
  that aim to:\n\n	Identify\, validate or develop novel pharmacological and
  non-pharmacological therapies through any of the pre-clinical stages of t
 he therapeutics discovery and development process (from early screening ca
 mpaigns to pre-clinical characterization nd testing). Therapies can addres
 s any PD motor or non-motor symptoms or could be aimed at preventing\, sto
 pping or delaying disease progression.\n\n\n\n	Test repurposed/repositione
 d therapies hitting priority PD pathways/targets in pre- clinical PD model
 s.\n\n\nFor this program\, MJFF will not consider proposals focused on the
  following:\n\n	Applications for target identification\, proposing early d
 iscovery studies to identify new targets (e.g.\, large-scale screening or 
 genomic/transcriptomic analyses).\n	Applications proposing genetic model s
 ystems and/or genetic manipulation to validate biological targets\, except
  if used as therapeutic approach(es).\n	Clinical trials\n\nFunding:    
    No set funding ceiling\n\nDuration:      24 months\n\nEligibilit
 y: Applications may be submitted by researchers or clinicians in:\n\n\n	U.
 S. and non-U.S. biotechnology/pharmaceutical/medical device companies\, or
  other publicly or privately held for-profit entities\; and\n\n\n\n	U.S. a
 nd non-U.S. public and private non-profit entities\, such as universities\
 , colleges\, hospitals\, laboratories\, units of state and local governmen
 ts\, and eligible agencies of the federal government in collaboration with
  biotechnology/pharmaceutical/medical device companies\, or other publicly
  or privately held for-profit entities.\n	Post-doctoral fellows are eligib
 le to apply as co-investigators with the designation of an administrative 
 primary investigator who directs the laboratory in which the fellow will c
 onduct research.\n\n\nHow to Apply: The two-stage application process begi
 ns with an LOI\, which can be submitted on a rolling basis on the MJFF Gra
 nt Portal. Instructions for submitting LOIs can be found here. Selected ap
 plicants will be notified within two weeks\, and will be invited to submit
  a full proposal by one of the four deadlines (see below). Budgets should 
 be formulated to include 15% OH.\n\nDeadlines (full proposals):     
       12 January 2023\n                       
                                       23
  March 2023\n                              
                                25 May 2023\n 
                                      
                        27 July 2023\n\nFurther informati
 on\n\n\n	More information about the program is available here\n	For any ot
 her questions\, please contact the Research Office\n\n\n 
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR